Abstract— Recent studies have shown that ultraviolet (UV) irradiation induces a systemic effect which enhances subsequent tumor induction by benzo[a]pyrene in a manner which is dependent on the dose of benzo[a]pyrene. The present study was designed to test whether UV‐B irradiation renders mice susceptible to subcutaneous or intravenous injection of a regressor tumor induced by benzo[a]pyrene. The sources of UV‐B irradiation were banks of 6 Westinghouse FS‐40 sunlamps, situated 20 cm above the mouse cages. Female BALB/cAnNHsd received five 30‐min dorsal UV‐B radiation treatments per week for 12 weeks, resulting in a total dose of approx. 6.4 × 105 J m‐2. Two to seven days after termination of UV treatments, syngeneic regressor tumor cells (BP2) induced by benzo[a]pyrene were injected subcutaneously or intravenously into irradiated mice and unirradiated controls. By 38 days post subcutaneous implantation, 24/30 and 3/30 BP2 implants were detectable in the irradiated and unirradiated mice, respectively. Ultraviolet irradiated mice were also unable to reject lung colonies resulting from intravenous administration of BP2 cells, although they were rejected by unirradiated mice. The mean number of lung colonies per mouse was 16‐ to 35‐fold greater in UV irradiated mice than in unirradiated controls, at 14 to 17 days post injection. Thus, UV irradiation rendered mice, with no known exposure to benzo[a]pyrene, susceptible to a subcutaneous or intravenous injection of a regressor tumor induced by benzo[a]pyrene.
|Original language||English (US)|
|Number of pages||4|
|Journal||Photochemistry and Photobiology|
|Publication status||Published - Jan 1 1991|
ASJC Scopus subject areas
- Physical and Theoretical Chemistry